Skip to main content
. 2026 May 29;14(6):1234. doi: 10.3390/biomedicines14061234
4NQO 4-nitroquinoline 1-oxide
a.u. arbitrary units
AUC Area under the ROC curve
CI Confidence interval
cv-AUC cross-validated area under the curve
H&E Hematoxylin and eosin
HC Healthy control
MOI Mean optical intensity
MiD Mild dysplasia
MoD Moderate dysplasia
NBI Narrow-band imaging
OLK Oral leukoplakia
OSCC Oral squamous cell carcinoma
ROC Receiver operating characteristic
ROI Region of interest
SCC Squamous cell carcinoma
SD Severe dysplasia